Form 8-K - Current report:
SEC Accession No. 0001493152-26-026414
Filing Date
2026-05-29
Accepted
2026-05-29 17:00:24
Documents
11
Period of Report
2026-05-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 40193
  Complete submission text file 0001493152-26-026414.txt   204795

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE scnx-20260526.xsd EX-101.SCH 3017
3 XBRL LABEL FILE scnx-20260526_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE scnx-20260526_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3095
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 261045739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)